Effect of triol treatment on migration and invasion of PC-3, DU-145, and CDXR-3 cells.
- Ching-Yu Lin (151493)
- Chieh Huo (421489)
- Li-Kuo Kuo (421490)
- Richard A. Hiipakka (421491)
- Richard Baker Jones (421492)
- Hui-Ping Lin (184894)
- Yuwen Hung (421493)
- Liang-Cheng Su (388502)
- Jen-Chih Tseng (421494)
- Ying-Yu Kuo (421495)
- Yu-Ling Wang (146366)
- Yasuhisa Fukui (290334)
- Yung-Hsi Kao (421496)
- John M. Kokontis (421497)
- Chien-Chih Yeh (421498)
- Linyi Chen (169104)
- Shiaw-Der Yang (421499)
- Hsiao-Hui Fu (421500)
- Ya-Wen Chen (142312)
- Kelvin K. C. Tsai (421501)
- Jang-Yang Chang (208285)
- Chih-Pin Chuu (3944804)
Publication date
June 2013
DOIAbstract
<p>PC-3, DU-145, and CDXR-3 cells were pre-treated with 0, 10, or 20 µM triol for 48 hrs. Cells were then counted and seeded at identical number. Cancer cell migration ability (A) and invasion ability (B) was determined by transwell migration assay (A) and transwell invasion assay 6 hrs (A) and 24 hrs (B) after cell seeding, respectively. (C) Migration of CDXR-3 cells was determined by transwell migration assay 24 hrs after cell seeding. There was no triol in medium during the migration or invasion assay. Asterisk *** represents statistically significant difference (<i>p</i><0.001) between the control group and triol treatment group.</p
Add to ORKG